financetom
Business
financetom
/
Business
/
Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care
Sep 15, 2025 4:11 AM

ALPHARETTA, Ga., Sept. 15, 2025 /PRNewswire/ -- Avanos Medical, Inc. ( AVNS ) , a leading medical technology company, today announced the acquisition of Nexus Medical, LLC, a privately held medical device company based in Lenexa, Kansas.

Nexus is the maker of the proprietary TKO® anti-reflux needleless connector technology, designed to support safer, more consistent nutrition and medication delivery in high-acuity settings, including Neonatal and Pediatric Intensive Care Units (NICUs and PICUs).

The acquisition adds complementary technology to Avanos' Specialty Nutrition Systems business and reinforces the company's focus on safe, reliable therapy delivery for the neonatal patient population.

"This acquisition is a clear extension of our strategy to deliver smarter, safer solutions across the critical care spectrum," said Dave Pacitti, Avanos chief executive officer. "We are proud to add the Nexus TKO® technology and the full breadth of Nexus' offerings to our portfolio as we continue investing in meaningful innovation that helps clinicians provide consistent care and improve outcomes for patients who need it most."

The TKO® needleless connector features a patented, pressure-activated tri-seal silicone valve that minimizes blood reflux – a known contributor to catheter occlusions, therapy delays, and infection risk during IV-based nutrition and medication delivery.*

"Nexus TKO® fits naturally into our Specialty Nutrition Systems business and is expected to deliver immediate value in NICU and PICU care," said Kerr Holbrook, Avanos' chief commercial officer. "It's a practical, trusted solution that helps clinicians reduce disruptions and deliver therapy with greater consistency and ease."

Avanos financed the acquisition with available cash. The company expects the acquisition to be immediately accretive to both revenue growth and earnings per share.

About Avanos Medical ( AVNS )

Avanos Medical ( AVNS ) is a medical technology company focused on delivering clinically superior medical device solutions that help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple product categories. For more information, visit www.avanos.com and follow Avanos Medical ( AVNS ) on X (@AvanosMedical), LinkedIn and Facebook.

About Nexus Medical

Founded in 2001, Nexus Medical invented the anti-reflux category in needleless connectors to solve the unintended consequences of blood reflux in IV catheters, including intraluminal thrombotic occlusions, catheter failure, and infections. As the most studied needleless connector on the market, the Nexus TKO® anti-reflux technology is an evidence-based way to simplify the complexity of IV therapy and improve patient safety. For more information, call (913) 451-2234 or visit www.nexusmedical.com.

*CLAIM ON FILE

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-acquires-nexus-medical-to-strengthen-nutrition-and-medication-delivery-in-critical-care-302555789.html

SOURCE Avanos Medical ( AVNS )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Wells Fargo earnings climb as investment banking shines
Wells Fargo earnings climb as investment banking shines
Jan 15, 2025
(Reuters) -Wells Fargo's ( WFC ) profit climbed in the fourth quarter, buoyed by stronger investment banking earnings, it said on Wednesday. The company's shares rose 3.1% to $73.40 in premarket trading. Wall Street was bolstered by a rebound in activity last year. Increasing confidence spurred companies to issue equity and debt. Corporations also struck deals, lifting volumes from a...
Wells Fargo earnings climb as investment banking shines
Wells Fargo earnings climb as investment banking shines
Jan 15, 2025
Jan 15 (Reuters) - Wells Fargo's ( WFC ) profit climbed in the fourth quarter, buoyed by stronger investment banking earnings. The fourth-largest U.S. lender's net income rose to $5.08 billion, or $1.43 per share, it said on Wednesday. That compares with $3.45 billion, or 86 cents per share, a year earlier. ...
Wells Fargo Q4 Earnings Rise, Revenue Falls
Wells Fargo Q4 Earnings Rise, Revenue Falls
Jan 15, 2025
06:53 AM EST, 01/15/2025 (MT Newswires) -- Wells Fargo ( WFC ) reported Q4 earnings Wednesday of $1.43 per diluted share, up from $0.86 a year earlier. Analysts polled by FactSet expected $1.35. Total revenue for the quarter ended Dec. 31, expressed as the sum of net interest income and noninterest income, was $20.38 billion, compared with $20.48 billion a...
Russian oil products trapped at sea by US sanctions, LSEG data shows
Russian oil products trapped at sea by US sanctions, LSEG data shows
Jan 15, 2025
MOSCOW (Reuters) - Nearly 500,000 metric tons of Russian oil products are trapped on tankers hit by U.S. sanctions, LSEG data showed on Wednesday. On Jan. 10, new Russia-related sanctions targeted more than 180 vessels and insurance companies, adding to the impact of similar restrictions imposed by United Kingdom and Europe Union. The vessels under the latest U.S. sanctions include...
Copyright 2023-2026 - www.financetom.com All Rights Reserved